Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).

T 1208/97 (Analogs/AMGEN) of 3.11.2000

European Case Law Identifier:

ECLI:EP:BA:2000:T120897.20001103

Date of decision:

03 November 2000

Case number:

T 1208/97

Application number:

IPC class:

Language of proceedings:

EN

Distribution:

C

Download and more information:

Decision text in EN (PDF, 34Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	Unpublished

Title of application:

SUBTILISIN ANALOGS

Applicant name:

Amgen Inc.

Opponent name:

(01) Novo Nordisk A/S
(02) Unilever N.V.

Board:

3.3.04

Headnote:

-

Relevant legal provisions:

European Patent Convention 1973 Art 108
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
European Patent Convention 1973 R 65(1)

Keywords:

Appeal of Opponent 01 - inadmissible
Main request - novelty (no)
Auxiliary request - novelty (yes) - disclaimer
Inventive step (yes)

Catchwords:

-

Cited decisions:

G 0002/88
T 0161/82
T 0165/84
T 0626/91
T 0312/94
T 0337/95

Citing decisions:

T 0932/99
T 0950/99
T 0885/02
T 0224/03
T 0656/03
T 0223/05
T 0334/06
T 1374/06
T 1736/06
T 0491/07
T 2017/07
T 2049/07
T 0238/08
T 0295/08
T 0299/09
T 0738/10
T 1190/11
T 2592/12
T 1634/15

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t971208eu1.html

Date retrieved: 17 May 2021

19 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: I Patentability

X CLR I C 5.2 Distinguishing features

Case Law Book: II Conditions to be met by an Application

X CLR II A 6.3.2 Relevance of Article 69 EPC

X CLR II A 6.3.4 Reading additional features and limitations into the claims

Case Law of the Enlarged Board

X G 0002/88 (Friction reducing additive) of 11.12.1989

General Case Law

X T 0161/82 (Electrical contact) of 26.6.1984

X T 0165/84 () of 29.1.1987

X T 0312/94 () of 4.9.1997

X T 0337/95 (Lower alkyl) of 30.1.1996

X T 0932/99 () of 3.8.2004

X T 0950/99 (Decay accelerating factor/GENENTECH) of 11.11.2002

X T 0885/02 (Paroxetine methanesulfonate/SMITHKLINE BEECHAM) of 15.12.2004

X T 0223/05 (Tyrosine kinase inhibitors/WARNER-LAMBERT) of 24.4.2007

X T 1736/06 () of 28.4.2010

X T 2017/07 (Hair dye composition/KAO) of 26.11.2009

X T 2049/07 () of 8.9.2009

X T 0295/08 (Skin cleansing composition/COLGATE-PALMOLIVE) of 3.2.2011

X T 0299/09 () of 8.6.2011

X T 1190/11 () of 28.3.2012

X T 1634/15 (CODIS core STR loci forensic human identification/PROMEGA) of 14.10.2016